Fig. 4
Comparison of OS in ESCC patients aged > 60 years (C: Chemotherapy group, CC: Chemotherapy plus camrelizumab group)
Fig. 4 | World Journal of Surgical Oncology
Comparison of OS in ESCC patients aged > 60 years (C: Chemotherapy group, CC: Chemotherapy plus camrelizumab group)